Antimicrobial and Antiviral Properties MB generates ROS under light exposure, disrupting bacterial membranes and nucleic acids
This blog, based on IQVIAs 18th March 2026 webinar on the future of the Obesity Medicines market, looks ahead to the next phase of that transformation, examining how the obesity market evolves from 2026 to 2030, and how the drivers of success shift from rapid adoption to differentiation, longterm performance and systemlevel impact
Many in your shoes have faced the same dilemmas, only to find success through expert guidance and accurate information
10.1016/S2213-2600(13)70294-7 Lancet Respir Med
Neuroinflammation in Alzheimers disease
Learn More Core Longevity Panel Measure 40+ key biomarkers critical to health and longevity, with age-related disease assessment and inflammation analysis, all available with an easy-to-read report delivered within 2 weeks